Abstract The BPC-157 10mg peptide pen features a high-concentration solution of the Body Protection Compound-157, a synthetic pentadecapeptide (15-amino acid sequence) derived from a protective protein found naturally in human gastric juice. BPC-157 is distinguished by its exceptional stability and its potent angiogenic properties. Unlike traditional growth factors that act directly on specific receptors, BPC-157 appears to modulate the Nitric Oxide (NO) system and upregulate the expression of Vascular Endothelial Growth Factor (VEGF), facilitating rapid revascularisation of ischaemic or damaged tissues. This 10mg formulation is the premier reagent for research into soft tissue repair (tendon, ligament, muscle), gastrointestinal mucosal integrity, and the “gut-brain” axis.

Mechanism and Research Interest

Primary Biological Pathway: Angiogenesis and NO Modulation The defining mechanism of BPC-157 is the promotion of angiogenesis—the formation of new blood vessels from pre-existing ones. It activates the VEGFR2 pathway, which is critical for endothelial cell survival and proliferation. Furthermore, BPC-157 modulates the eNOS (endothelial Nitric Oxide Synthase) system. Research utilising the 10mg pen focuses on this interaction, specifically investigating how BPC-157 maintains the NO balance to prevent vasoconstriction during tissue injury while promoting the vasodilatation required for nutrient delivery to the repair site.

Secondary Research Finding: Tendon and Ligament Healing (FAK-Paxillin) BPC-157 is extensively investigated for its ability to accelerate the healing of avascular tissues like tendons and ligaments. It stimulates the migration and proliferation of tendon fibroblasts (tenocytes) via the activation of the FAK-Paxillin pathway. The 10mg formulation is utilised in rat Achilles tendon transection models to quantify the restoration of biomechanical integrity (load-to-failure strength) and the reduction of inflammatory infiltrates during the early phases of healing.

Tertiary Research Finding: Gastrointestinal Cytoprotection Originally isolated from gastric juice, BPC-157 is a potent cytoprotective agent. It has been shown to heal fistulas (rectovaginal, enterocutaneous) and protect against NSAID-induced enteropathy. Researchers use the 10mg pen in models of Colitis (IBD) to measure the reduction in ulcer area and the preservation of mucosal architecture, hypothesizing that it counteracts the “leaky gut” phenomenon by reinforcing tight junction proteins.

Long-term Genomic and Safety Observations A unique aspect of BPC-157 research is its safety profile; no lethal dose (LD50) has been achieved in rodent models. Genomic studies utilising the 10mg dose investigate the upregulation of the EGR-1 (Early Growth Response-1) gene, a master regulator of wound repair and cytokine response. This data helps position BPC-157 as a modulator of the healing cascade rather than a direct mitogen.

Product Specifications

• Purity: Validated at >99+% via High-Performance Liquid Chromatography (HPLC). We ensure the peptide sequence is free from truncation errors, which is vital given the length (15-mer) relative to shorter peptides.

• Appearance: The 3ml pen contains a clear, colourless, sterile liquid.

• Precision: The pen delivery system ensures accurate volumetric dosing. The 10mg concentration allows for the delivery of higher doses (e.g., 10$\mu$g/kg vs 100ng/kg) to determine the biphasic dose-response curve often observed in BPC-157 studies.

• Storage: The product must be stored at 2∘C to 8∘C.

Storage and Shipping Guidelines

Refrigeration and Shelf Life The BPC-157 10mg Pen contains a remarkably stable peptide. While it is resistant to gastric acid hydrolysis, it still requires refrigeration (2∘C to 8∘C) to maintain long-term sterility and concentration. The shelf life is 12 months in the sealed state. Once the pen is accessed, the bacteriostatic environment preserves the solution for 28 days.

Shipping Stability We utilise medical-grade thermal packaging. The peptide is stable for up to 72 hours at ambient UK temperatures. BPC-157 is one of the few peptides that can withstand short-term temperature excursions without significant degradation. However, to ensure the highest fidelity for research, we recommend selecting the fastest available shipping option.

Freezing Warning Do not freeze. Freezing can cause the peptide to precipitate. Although BPC-157 is robust, freeze-thaw cycles can induce aggregation which alters the pharmacokinetics of the solution, potentially affecting the rate of absorption in subcutaneous vs. intramuscular injection models. A frozen pen should be discarded.

Why Choose the Peptide Pro 3ml Pen Format?

The BPC-157 10mg Pen is the definitive tool for Systemic and Local Repair Research. Standard vials require manual mixing, which introduces sterility risks, particularly when injecting directly into joint spaces or tendon sheaths where infection is catastrophic to the study.

Our 10mg pen provides a high-capacity, sterile source. It is ideal for “local” administration protocols (e.g., peri-tendinous injection) as well as systemic dosing (e.g., via drinking water models or IP injection) where higher total milligram amounts are consumed over the course of the experiment.

For researchers investigating complementary repair mechanisms, we recommend examining:

• TB-500 10mg:  (Targets Actin for cell motility; often paired with BPC-157).

• GHK-Cu 50mg: (Targets Collagen synthesis and matrix remodelling).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection (e.g., for injury recovery, treating IBD, or athletic performance enhancement), therapeutic use, or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.